Prof. Dr. med. Stephan Achenbach

Lehrstuhl für Innere Medizin II

Rotational atherectomy via the transradial access: success rates, procedural parameters and complications (2022) Ferstl P, Drentwett AS, Bargon S, Schacher N, Tröbs M, Marwan M, Achenbach S, Gaede L Journal article Clinical applications of cardiac computed tomography: a consensus paper of the European Association of Cardiovascular Imaging-part I (2022) Pontone G, Rossi A, Guglielmo M, Dweck MR, Gaemperli O, Nieman K, Pugliese F, et al. Journal article European Society of Cardiology: cardiovascular disease statistics 2021 (2022) Timmis Chair Writing Group A, Vardas P, Townsend N, Torbica A, Katus H, De Smedt D, Gale CP, et al. Journal article Computed Tomography–Derived Fractional Flow Reserve: An Invitation to Learn More (2022) Achenbach S Journal article Association of Plaque Location and Vessel Geometry Determined by Coronary Computed Tomographic Angiography With Future Acute Coronary Syndrome-Causing Culprit Lesions (2022) Han D, Lin A, Kuronuma K, Tzolos E, Kwan AC, Klein E, Andreini D, et al. Journal article Associations between dyspnoea, coronary atherosclerosis, and cardiovascular outcomes: results from the long-term follow-up CONFIRM registry (2022) van Rosendael AR, Bax AM, van den Hoogen IJ, Smit JM, Al'Aref SJ, Achenbach S, Al-Mallah MH, et al. Journal article CODE-EHR best-practice framework for the use of structured electronic health-care records in clinical research. (2022) Kotecha D, Asselbergs FW, Achenbach S, Anker SD, Atar D, Baigent C, Banerjee A, et al. Journal article, Review article CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research. (2022) Kotecha D, Asselbergs FW, Achenbach S, Anker SD, Atar D, Baigent C, Banerjee A, et al. Journal article Prognostic Significance of Nonobstructive Left Main Coronary Artery Disease in Patients With and Without Diabetes: Long-Term Outcomes From the CONFIRM Registry (2022) Lee J, Shaikh K, Nakanishi R, Gransar H, Achenbach S, Al-Mallah MH, Andreini D, et al. Journal article The SGLT2 inhibitor empagliflozin reduces tissue sodium content in patients with chronic heart failure: results from a placebo-controlled randomised trial (2022) Kolwelter J, Kannenkeril D, Linz P, Jung S, Nagel AM, Bosch A, Ott C, et al. Journal article